Diabetes and atherogenesis

被引：29

作者：

Fisher, M ^{[1
]}

机构：

[1] Glasgow Royal Infirm, Ward 4, Glasgow G4 0SF, Lanark, Scotland

[2] Glasgow Royal Infirm, Ward 5, Glasgow G4 0SF, Lanark, Scotland

来源：

HEART | 2004年 / 90卷 / 03期

关键词：

D O I：

10.1136/hrt.2003.018622

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：336 / 340

页数：5

共 20 条

[1] HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects - Prospective data from the Verona Diabetes Complicated Study [J].

Bonora, E ;

Formentini, G ;

Calcaterra, F ;

Lombardi, S ;

Marini, F ;

Zenari, L ;

Saggiani, F ;

Poli, M ;

Perbellini, S ;

Raffaelli, A ;

Cacciatori, V ;

Santi, L ;

Targher, G ;

Bonadonna, R ;

Muggeo, M .

DIABETES CARE, 2002, 25 (07) :1135-1141

[2] Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy [J].

Brenner, BM ;

Cooper, ME ;

de Zeeuw, D ;

Keane, WF ;

Mitch, WE ;

Parving, HH ;

Remuzzi, G ;

Snapinn, SM ;

Zhang, ZX ;

Shahinfar, S .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (12) :861-869

[3] Point: Diabetic patients and coronary calcium: Risk stratification, compliance, and plaque progression [J].

Budoff, MJ .

DIABETES CARE, 2003, 26 (02) :541-542

[4]

Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3

[5]

Diabet Control Complications Trial DCCT Res Grp, 1995, AM J CARDIOL, V75, P894

[6] EVIDENCE FOR A SPECIFIC HEART-DISEASE OF DIABETES IN HUMANS [J].

FISHER, BM ;

FRIER, BM .

DIABETIC MEDICINE, 1990, 7 (06) :478-489

[7]

Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981

[8] Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals [J].

Gerstein, HC ;

Mann, JFE ;

Yi, QL ;

Zinman, B ;

Dinneen, SF ;

Hoogwerf, B ;

Hallé, JP ;

Young, J ;

Rashkow, A ;

Joyce, C ;

Nawaz, S ;

Yusuf, S .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (04) :421-426

[9]

Gerstein HC, 2000, LANCET, V355, P253

[10] Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus [J].

Haffner, SM ;

Greenberg, AS ;

Weston, WM ;

Chen, HZ ;

Williams, K ;

Freed, MI .

CIRCULATION, 2002, 106 (06) :679-684

← 1 2 →